The gap between trailing and forward P/E suggests trailing earnings still carry depressed or distorted items relative to the run-rate implied by recent quarters. EV/EBITDA of 18.17x falling to 12.76x forward tells a similar story. Against a backdrop of 9% organic growth, a 20.80x forward multiple appears reasonable relative to disposable-device peers, though the trailing figure alone would look expensive and warrants adjustment for acquisition amortization before comparison.

Gross margin oscillating between 46.4% and 51.4% indicates limited pricing power, consistent with a disposables-heavy mix. The 2026Q3 operating margin of 14.1% is the strongest in the window, but its durability is unproven given the prior reversal. Investors should treat net margin, which benefited from below-the-line items, with more caution than operating margin when judging underlying earning power.

Low ROIC alongside a goodwill-heavy asset base suggests acquired capital is earning returns well below what the cost of capital would require. ROE of 2.5% in 2026Q3 is modest and largely reflects a rising equity base rather than improving profitability. The absence of meaningful ROIC expansion warrants monitoring of whether recent tuck-in acquisitions begin to lift returns.

The inventory-heavy cycle is consistent with a broad SKU catalog and custom tray configurations, which lengthen holding periods. DSO near 0.14 to 0.15 indicates collections are efficient, so the cycle lengthening is primarily an inventory and supplier-timing matter. Rising inventory relative to sales could signal obsolescence exposure as clinical guidelines shift.

The decline in leverage alongside equity growth suggests deleveraging rather than merely equity inflation, though acquisition-related equity effects cannot be fully excluded. Interest coverage dipping from 10.6x levels earlier in the window to 8.61x in 2026Q3 is worth monitoring but remains well above stress thresholds. Refinancing risk appears limited based on the reported debt levels.

A quick ratio near 3.0 indicates liquidity does not depend heavily on inventory conversion, which is useful given the inventory-heavy cash cycle. Under severe stress, the liquidity position would appear to hold, though the goodwill-heavy balance sheet means tangible liquidity coverage is lower than headline ratios imply. Investors should monitor whether working capital absorption continues to draw down cash.